InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX)
CUSIP: N44821101
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Shares, nominal value (euro)0.12 per share
- Shares outstanding
- 67,811,197
- Total 13F shares
- 3,514,581
- Share change
- -89,925
- Total reported value
- $17,683,000
- Price per share
- $5.03
- Number of holders
- 31
- Value change
- -$293,543
- Number of buys
- 19
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP N44821101?
CUSIP N44821101 identifies IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N44821101:
Top shareholders of IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
1,007,559
|
$4,292,000 | — | 30 Sep 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
678,525
|
$2,891,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.9%
|
613,062
|
$2,612,000 | — | 30 Sep 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.52%
|
350,000
|
$1,491,000 | — | 30 Sep 2020 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.31%
|
208,601
|
$889,000 | — | 30 Sep 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.22%
|
149,750
|
$637,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
107,674
|
$459,000 | — | 30 Sep 2020 | |
| Verition Fund Management LLC |
13F
|
Company |
0.13%
|
90,000
|
$383,000 | — | 30 Sep 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.1%
|
70,000
|
$298,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.07%
|
50,600
|
$216,000 | — | 30 Sep 2020 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.07%
|
47,961
|
$204,000 | — | 30 Sep 2020 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.07%
|
46,090
|
$196,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
43,806
|
$187,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
34,045
|
$145,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
31,190
|
$133,000 | — | 30 Sep 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
24,969
|
$106,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
14,516
|
$61,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
5,333
|
$23,000 | — | 30 Sep 2020 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.01%
|
5,000
|
$21,000 | — | 30 Sep 2020 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0%
|
3,000
|
$13,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,952
|
$9,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,869
|
$8,000 | — | 30 Sep 2020 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1,300
|
$6,000 | — | 30 Sep 2020 |
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q4 2020
As of 31 Dec 2020,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,514,581 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, MORGAN STANLEY, ORBIMED ADVISORS LLC, FNY Investment Advisers, LLC, Bank Julius Baer & Co. Ltd, Zurich, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Verition Fund Management LLC, Birchview Capital, LP, and SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
23
Q4 2020 holders
31
Holder diff
8
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.